Blitz Bureau New York, April 3 Because of the importance of India’s pharmaceuticals to US healthcare, those exports will get a reprieve from President Donald Trump’s reciprocal tariffs, according to the White House. The US is the largest importer of pharmaceuticals from India, bringing in products in the category worth $8.73 billion during the 2024…
…
A platform for change and progress. At Blitz India Business, our vision is to be a transformative platform that elevates the role of business and industry in driving India’s journey towards Viksit Bharat 2047. We are dedicated to fostering innovation, championing sustainability, and promoting inclusivity, while building a bridge for collaboration and progress.
Quick Links
Get important news delivered directly to your inbox and stay connected!